Research Topics
| Andrew YoungSummaryAffiliation: Emory University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Beta defensin-1, parvalbumin, and vimentin: a panel of diagnostic immunohistochemical markers for renal tumors derived from gene expression profiling studies using cDNA microarraysAndrew N Young
Department of Pathology, Emory University, Atlanta, Georgia, USA
Am J Surg Pathol 27:199-205. 2003..This work demonstrates that a useful panel of immunohistochemical markers can be derived from differential gene expression profiles determined using cDNA microarrays...
Nanomolecular histopathology for renal tumor classificationAndrew Young
Emory University and the Atlanta VA Medical Center, Decatur, GA 30033 USA phone 404 321 6111 ext 3441 fax 404 235 3007 e mail
Conf Proc IEEE Eng Med Biol Soc 1:723-6. 2005..Our preliminary data suggests that SERS-IHC can be performed using standard microscopic equipment, with potential for sensitive, quantitative multiplex assays on fixed tissues...
Absolute preoperative C-reactive protein predicts metastasis and mortality in the first year following potentially curative nephrectomy for clear cell renal cell carcinomaT V Johnson
Department of Urology, School of Medicine, Emory University, Atlanta, Georgia 30322, USA
J Urol 183:480-5. 2010..Considering the continuous range of C-reactive protein (less than 1 mg/l to greater than 100 mg/l) we assessed the ability of absolute preoperative C-reactive protein to predict metastases and mortality as a continuous variable...
Initial experience with the radiotracer anti-1-amino-3-[18F]Fluorocyclobutane-1-carboxylic acid (anti-[ 18F]FACBC) with PET in renal carcinomaDavid M Schuster
Department of Radiology, Division of Nuclear Medicine, Emory University, Atlanta, GA 30322, USA
Mol Imaging Biol 11:434-8. 2009..The present study examines anti-[(18)F]FACBC positron emission tomography uptake in patients with renal masses...
